Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston
3
×
boston blog main
boston top stories
life sciences
national blog main
clinical trials
deals
national top stories
startups
480 biomedical
ally bridge group
arsenal medical
azacitidine
beta-thalassemia
big data analytics
blackrock
bob langer
casdin capital
chronic rhinosinusitis
covid-19
dacogen
decitabine
diabetic nephropathy
dna
drug delivery
epigenetics
epizyme
eventide asset management
farydak
fda
flagship pioneering
focal segmental glomerulosclerosis
fulcrum therapeutics
genzyme
george whitesides
goldfinch bio
inflammation
insulated genomic domains
investing
What
biotech
3
×
new
3
×
company
developing
ipo
medicines
million
raised
raises
therapeutics
aims
analysis
approach
based
bio
bring
called
debut
debuts
develop
diseases
drug
drugs
employing
epigenetic
epigenetics
field
flagship’s
genetic
goldfinch
kidney
late
later
lead
lyra
markets
morning
nose
noses
omega
Language
unset
Current search:
new
×
biotech
×
boston
×
biotech
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further